Lu Xu
No. 1 Youyi Road
Chongqing, 400016, China
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 07, 2026
Improved early response assessment of chemoimmunotherapy efficacy by 68Ga-grazytracer PET/CT in non-small cell lung cancer: a comparison of bronchial arterial versus intravenous chemotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 11, 2026
68Ga-pentixafor PET/CT imaging characteristics in primary aldosteronism with coexisting subclinical cushing syndrome: a retrospective cohort study.
Journal: EJNMMI research
Published: January 30, 2026
The diagnostic value of ⁶⁸Ga-FAPI PET/CT in patients with suspicious recurrent or metastatic differentiated thyroid cancer: a comparative study.
Journal: BMC medical imaging
Published: November 27, 2025
Machine learning-based model for prediction of KCNJ5 mutation in unilateral primary aldosteronism based on [68Ga]Ga-Pentixafor PET/CT.
Journal: EJNMMI research
Published: September 29, 2025
Impact of reduced 18F-MK6240 PET/MR acquisition duration on image quality and tau pathology assessment in patients with cognitive impairment.
Journal: EJNMMI physics
Published: September 28, 2025
Correlation analysis of 11C-CFT PET/CT parameters with clinical characteristics of patients with early to mid-stage Parkinson's disease.
Journal: BMC medical imaging
Published: September 22, 2024
Clinical Utility of Dual-Time 68Ga-Pentixafor PET/CT in Diagnosing and Subtyping Primary Aldosteronism.
Journal: Clinical endocrinology
Published: September 18, 2024
Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 10, 2024
Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson's disease and multiple system atrophy: a case control study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 06, 2024
Clinical value of 68Ga-pentixafor PET/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study.
Journal: EJNMMI research
Published: May 16, 2024
Last Updated: 09/26/2026